Trial intelligence / Profile preview

Preoperative Radiosurgery for Brain Metastases Planned for Surgical Resection

NCT04895592Phase 1Completed

Sponsor
Emory University
Start
Jul 2021
Primary completion
Sep 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 1, randomised, open-label trial of dexamethasone in brain metastases (2 arms), sponsored by Emory University. Primary endpoint: Incidence of adverse events grade 3 or greater at 4 months. Started Jul 2021; status: completed.

02

Drugs

dexamethasone
03

Conditions

brain metastases

Beyond the preview

Go deeper on NCT04895592.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04895592.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call